SAN DIEGO, March 12 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leading provider of intravascular ultrasound (IVUS) and functional measurement (FM) products designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that it will be participating in the Cowen and Company 28th Annual Health Care Conference on Monday, March 17.
The presentation by Scott Huennekens, president and chief executive officer, will begin at 3:15 p.m., Eastern Daylight Time (12:15 Pacific Daylight Time).
The presentation will be available through the conference website at http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=VOLC&item_id=17798 53 or via the company's website at http://www.volcanocorp.com .
Volcano Corporation (Nasdaq: VOLC) offers a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular disease and guide optimal therapies. The company's intravascular ultrasound (IVUS) product line includes ultrasound consoles that can be integrated directly into virtually any modern cath lab. Volcano IVUS offers unique features, including both single-use phased array and rotational IVUS imaging catheters, and advanced functionality options, such as VH(TM) IVUS tissue characterization and ChromaFlo(R). Volcano also provides functional measurement (FM) consoles and single-use pressure and flow guide wires. Currently, more than 3,200 Volcano IVUS and FM systems are installed worldwide, with approximately half of its revenues coming from outside the United States. For more information, visit the company's website at http://www.volcanocorp.com .
|SOURCE Volcano Corporation|
Copyright©2008 PR Newswire.
All rights reserved